INHIBITOREN VON KREBS UND/ODER METASTASIS

European patent · EP3538101 · In force

Register entry

Publication number
EP3538101
Application number
EP17868916
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 14, 2017
Published
Sep 18, 2019
Granted
Jun 19, 2024
Protection ends at the latest
Nov 13, 2037
Next annual fee due
Nov 30, 2026
IPC classes
C07D 487/04 (2006.01)
A61K 31/519 (2006.01)
A61P 35/00 (2006.01)
Priority
US 201662421468 P 14.11.2016
US 201662424571 P 21.11.2016
PCT application
PCT/US2017/061443 14.11.2017
PCT publication
WO2018/089967 17.05.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 27, 2026

    Change

    Published in Swissreg on 27.03.2026

  2. Apr 30, 2025

    Change

    Published in Swissreg on 30.04.2025

  3. Dec 9, 2024

    Change

    Published in Swissreg on 09.12.2024

  4. Sep 23, 2024

    Agent entered

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 23.09.2024

  5. Jun 19, 2024

    Granted

    Published in Swissreg on 19.06.2024

Parties

Inventor

KEGELMAN, Timothy P.

Richmond VA 23298, US

PELLECCHIA, Maurizio

Riverside CA 92521, US

WU, Bainan

Richmond VA 23298, US

DE, Surya K.

Richmond VA 23298, US

EMDAD, Luni

Richmond VA 23298, US

MENEZES, Mitchell E.

Richmond VA 23298, US

DAS, Swadesh K.

Richmond VA 23298, US

WEI, Jun

La Jolla CA 92037, US

FISHER, Paul B.

Henrico VA 23238, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.